Abstract
The transplantation of mesenchymal stem cells (MSC) is becoming a promising treatment for osteoarthritis (OA), as well the intra-articular application of hyaluronic acid (HA), that has been shown effective in pain reduction and supporting the homeostasis in the articular environment. Moreover, the combination of HA with MSC has been demonstrated as a therapeutic potential for OA treatment…